Investigational products used in clinical trials for public health emergency, rare disease, cancer HIV/AIDS and emerging and re-emerging infectious disease of public health threats

Guidelines on Regulatory Reliance on the Conduct of Clinical Trials in the Philippines

There are major changes on the issuance, specifically on the objectives, scope and coverage and application process.